Dichlorphenamide Tablet
Product Images NDC 16571-242

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dichlorphenamide (NDC 16571-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diclorophenamide-label.jpg (Diclorophenamide Label)

Label for Dichlorphenamide Tablets, USP 50 mg oral tablets by Rising Pharma Holdings, Inc. The label indicates a bottle containing 100 tablets, marked Rx only, with storage instructions and a barcode. Manufactured in India with NDC 16571-242-01.*

FDA Label Image

Diclorophenamide-table 1.jpg (Diclorophenamide Table 1)

A data table listing adverse reactions observed in clinical studies comparing Dichlorphenamide (N=36) and placebo (N=29). It categorizes reactions by system (nervous, gastrointestinal, general, musculoskeletal, respiratory, skin) and shows the percentage of subjects experiencing each reaction under Dichlorphenamide and placebo groups.*

FDA Label Image

Diclorophenamide-label.jpg (Diclorophenamide Structure)

Chemical structure of dichlorphenamide showing a benzene ring substituted with two chlorine atoms and two sulfonamide groups, indicating its molecular configuration as an oral tablet active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.